vTv Therapeutics (VTVT) Misses Q2 EPS by 81c

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.81).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Meta jury finds company misled New Mexico residents
• Active options: MSTR GME GOOGL SMCI PLTR MARA IREN ORCL HOOD DELL